Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
McKinsey
Queensland Health
McKesson
Express Scripts
Moodys
Teva
Harvard Business School

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020719

« Back to Dashboard

NDA 020719 describes PRELAY, which is a drug marketed by Sankyo and is included in one NDA. Additional details are available on the PRELAY profile page.

The generic ingredient in PRELAY is troglitazone. Additional details are available on the troglitazone profile page.
Summary for 020719
Tradename:PRELAY
Applicant:Sankyo
Ingredient:troglitazone
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength200MG
Approval Date:Jan 29, 1997TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength400MG
Approval Date:Jan 29, 1997TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength300MG
Approval Date:Aug 4, 1997TE:RLD:No

Expired US Patents for NDA 020719

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sankyo PRELAY troglitazone TABLET;ORAL 020719-002 Jan 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-001 Jan 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-001 Jan 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Sankyo PRELAY troglitazone TABLET;ORAL 020719-001 Jan 29, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
Harvard Business School
Chinese Patent Office
Merck
Colorcon
Medtronic
AstraZeneca
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.